Immune to Cancer: The CRI Blog
-
Brad Silver’s Immunotherapy Story
Brain Cancer | Diagnosed 2003 What I loved is that there were no weird foreign medicines in it…. -
Barbara L’s Immunotherapy Story
Ovarian Cancer | Diagnosed 2009 When we get the vaccine done, I think I’m only there about a… -
Jeannine Walston’s Immunotherapy Story
Brain Cancer | Diagnosed 1998 I absolutely know that further improved quality of life, enhanced survival, and cures… -
Henrik Vad Madsen’s Immunotherapy Story
Melanoma | Diagnosed 2003 My approach was to say: I have cancer, but I want to have a… -
Helena Benítez’s Immunotherapy Story
Melanoma | Diagnosed 1994 I don’t have a problem with dying. For me, the problem is living and… -
Pembrolizumab Approved for Children and Adults with Hard-to-Treat Hodgkin Lymphoma
Pembrolizumab is second anti-PD-1 drug approved for adults with cHL, first for any childhood cancer
-
Donald (Dee) Rowe’s Immunotherapy Story
Melanoma | Diagnosed 2005 Every day is a bonus. Donald (Dee)’s Story Donald (Dee) Rowe loves his job… -
Donald Foley’s Immunotherapy Story
Sarcoma | Diagnosed Age 13 Every day I would feel my shoulder, and I could notice a difference…. -
Diane Altenburg’s Immunotherapy Story
Breast Cancer I thought, ‘What else can I do to help my daughters, my nieces?’ Diane’s Story…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.